Results 231 to 240 of about 236,137 (343)
Management of the Neuropsychiatric and Cognitive Symptoms in Parkinson’s Disease [PDF]
Haşmet Hanağası, Murat Emre
openalex +1 more source
Advanced Microfluidic‐Based Wearable Electrochemical Sensors for Continuous Biochemical Monitoring
Microfluidic‐based wearable electrochemical sensors are transforming non‐invasive health monitoring through real‐time biochemical analysis of sweat, saliva, and interstitial fluid. This review explores advances in microfluidic design, fabrication, and sensor integration while addressing biofluid variability, material compatibility, and scalability.
Sehyun Park+5 more
wiley +1 more source
Magnetoelectric (ME) core–shell nanoparticles, particularly made of CoFe2O4‐BaTiO3, are emerging as promising materials for bioengineering applications. This perspective explores the evolution of measurement methodologies for their ME coefficient (α), highlighting variations in reported values.
Martina Lenzuni+4 more
wiley +1 more source
Parkinson’s Disease and Movement Disorders
Charles H. Adler, J. Eric Ahlskog
openalex +1 more source
Symposium 3: Function and Pathogenesis in Parkinson’s Disease. Synuclein: the third amyloid in Alzheimer's disease [PDF]
John Q. Trojanowski
openalex +1 more source
Issues Related to Studying Occupational Metal Exposures and Parkinson’s Disease
openalex +1 more source
PARKINSON’S DISEASE. A COMPLETE GUIDE FOR PATIENTS & FAMILIES. 2001. By W.J. Weiner, L.M. Shulman, and A.E. Lang. Published by Johns Hopkins Press. 256 pages. C$25.52 approx. [PDF]
Ali H. Rajput
openalex +1 more source
The prevalence of neurologically asymptomatic CSVD is common in the nondiabetic population. Glycated hemoglobin A1c correlated with periventricular white matter hyperintensities. Fasting blood glucose was associated with deep cerebral microbleeds. Better control of blood glucose may have a beneficial effect on reducing the risk of CSVD.
Xinxin Ma+7 more
wiley +1 more source